CD44 and central nervous system cancer: CD44 and TNFSF14 were significantly overexpressed in GBM compared to WHO Grade 3 glioma (confirmed by TCGA, CGGA, and Rembrandt), as well as LGG and normal brain tissue (confirmed by Rembrandt and qPCR analysis).